Owens & Minor Stock Dips On Mixed Q4 Preliminary Results & $310 Million Apria Goodwill Charge: Details

Comments
Loading...
Zinger Key Points

Owens & Minor, Inc. OMI shares dipped premarket on Monday after the company disclosed preliminary results and financing for the previously announced Rotech Healthcare Holdings, Inc. buyout.

Edward A. Pesicka, President & Chief Executive Officer of Owens & Minor, said, “We are commencing a process to raise additional debt while the capital markets are attractive, to finance our previously announced agreement to acquire Rotech which we continue to expect will close in the first half of 2025.”

”Our healthy free cash flow provides the vehicle for this proposed financing as well as helping us achieve our deleveraging goals over the next few years.” 

Notably, in July 2024, the company announced the acquisition of Rotech Healthcare for $1.36 billion in cash.

Preliminary Results: For the fourth quarter, Owens & Minor sees revenue of $2.67 billion – $2.70 billion (vs. consensus of $2.731 billion) and adjusted EPS of $0.52 –$0.55 (compared to the street view of $0.53).

For 2024, the company stated preliminary revenue of $10.67 billion – $10.70 billion (vs. $10.736 billion estimate) and adjusted EPS of $1.50 – $1.53 (vs. consensus of $1.51).

The company expects to witness a non-cash goodwill impairment charge of around $310 million within its Apria division, or a net loss of about $4.00 per share.

This reflects financial market changes in the fourth quarter of 2024, which include a decline in Owens & Minor’s stock price, rising interest rates, and anticipated pricing changes in a capitated contract.

Pesicka added, “We are particularly excited about the full-year performance of our Patient Direct segment which posted solid mid-single digit growth, and even higher in key categories.”

”In addition, we are pleased that in a year of meaningful reinvestment in the business we were able to reduce total debt by over $240 million.”

The company plans to report its fourth-quarter and full-year 2024 financial results on February 28, 2025.

Investors can gain exposure to the stock via Invesco Exchange-Traded Fund Trust II Invesco S&P SmallCap 600 Revenue ETFRWJ.

Price Action: OMI shares are down 8.71% at $13.00 premarket at the last check Monday.

Read Next:

Image via Shutterstock.

OMI Logo
OMIOwens & Minor Inc
$6.72-3.93%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
6.97
Growth
5.62
Quality
95.22
Value
38.45
Price Trend
Short
Medium
Long
Got Questions? Ask
Which healthcare stocks may benefit from OMI's acquisition?
How will Rotech's acquisition impact OMI's market position?
Which debt instruments could OMI pursue for financing?
How might interest rate changes affect OMI's debt strategy?
Which competitors could be vulnerable due to OMI's growth strategy?
How could goodwill impairment affect investor sentiment?
What opportunities are there in the home healthcare sector post-acquisition?
How might investor confidence shift after OMI's earnings report?
Which ETFs provide exposure to OMI's market?
What impact will stock price declines have on OMI's future acquisitions?
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: